Amy GilesIncreasing Engagement
Brenda SnowAuthentic Patient Voice
Paul TheisenPatient Acquisition
Liz KaneImpactful Strategy
Bud BilanichSuccess Coach
David LinetskyPoint-of-Care Marketing
Stacey GandlerBrand Nourishment
Suma Ramadas, PhDMedical Affairs
Daniel SontupeMarket Access
Matthew DurhamOmnidynamic Marketing
Pat PurcellMeeting Engagement
Frank BurrellScientific Storytelling
Joey CohenMedication Adherence
Matt TurnerPatient Affordability
EXPAND shows oral siponimod (BAF312) is the first potential therapy to meaningfully delay disability ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email